China vs Serbia: Cause of death, by non-communicable diseases, ages 0-4, male
China
31.7%
in 2021
Serbia
31.4%
in 2021
China rank
90th
Serbia rank
92nd
Cause of death, by non-communicable diseases, ages 0-4, male over time
- China
- Serbia
How they compare
China currently reports 31.7% against 31.4% in Serbia, a difference of 0.3%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Serbia ahead.
China ranks 90th and Serbia ranks 92nd of 185 countries.
Across the 3 decades both report, China averaged higher in 2 and Serbia in 1.
Head to head by decade
| Decade | China | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 18.1% | 30.6% | 12.5% | Serbia |
| 2010s | 30.2% | 29.9% | 0.3% | China |
| 2020s | 31.6% | 30.7% | 0.9% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, China or Serbia?
- China, at 31.7% against 31.4% in Serbia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between China and Serbia?
- 0.3%, with China ahead.
- How many years of comparable data are there for China and Serbia?
- 6 years are reported by both, from 2000 to 2021.
- How do China and Serbia rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- China ranks 90th and Serbia ranks 92nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.